Cargando…

Genomic reconstruction of the SARS-CoV-2 epidemic in England

The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus leads to new variants that warrant timely epidemiological characterization. Here we use the dense genomic surveillance data generated by the COVID-19 Genomics UK Consortium to reconstruct the dynamics of 71 diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Vöhringer, Harald S., Sanderson, Theo, Sinnott, Matthew, De Maio, Nicola, Nguyen, Thuy, Goater, Richard, Schwach, Frank, Harrison, Ian, Hellewell, Joel, Ariani, Cristina V., Gonçalves, Sonia, Jackson, David K., Johnston, Ian, Jung, Alexander W., Saint, Callum, Sillitoe, John, Suciu, Maria, Goldman, Nick, Panovska-Griffiths, Jasmina, Birney, Ewan, Volz, Erik, Funk, Sebastian, Kwiatkowski, Dominic, Chand, Meera, Martincorena, Inigo, Barrett, Jeffrey C., Gerstung, Moritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674138/
https://www.ncbi.nlm.nih.gov/pubmed/34649268
http://dx.doi.org/10.1038/s41586-021-04069-y
_version_ 1784615583243829248
author Vöhringer, Harald S.
Sanderson, Theo
Sinnott, Matthew
De Maio, Nicola
Nguyen, Thuy
Goater, Richard
Schwach, Frank
Harrison, Ian
Hellewell, Joel
Ariani, Cristina V.
Gonçalves, Sonia
Jackson, David K.
Johnston, Ian
Jung, Alexander W.
Saint, Callum
Sillitoe, John
Suciu, Maria
Goldman, Nick
Panovska-Griffiths, Jasmina
Birney, Ewan
Volz, Erik
Funk, Sebastian
Kwiatkowski, Dominic
Chand, Meera
Martincorena, Inigo
Barrett, Jeffrey C.
Gerstung, Moritz
author_facet Vöhringer, Harald S.
Sanderson, Theo
Sinnott, Matthew
De Maio, Nicola
Nguyen, Thuy
Goater, Richard
Schwach, Frank
Harrison, Ian
Hellewell, Joel
Ariani, Cristina V.
Gonçalves, Sonia
Jackson, David K.
Johnston, Ian
Jung, Alexander W.
Saint, Callum
Sillitoe, John
Suciu, Maria
Goldman, Nick
Panovska-Griffiths, Jasmina
Birney, Ewan
Volz, Erik
Funk, Sebastian
Kwiatkowski, Dominic
Chand, Meera
Martincorena, Inigo
Barrett, Jeffrey C.
Gerstung, Moritz
author_sort Vöhringer, Harald S.
collection PubMed
description The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus leads to new variants that warrant timely epidemiological characterization. Here we use the dense genomic surveillance data generated by the COVID-19 Genomics UK Consortium to reconstruct the dynamics of 71 different lineages in each of 315 English local authorities between September 2020 and June 2021. This analysis reveals a series of subepidemics that peaked in early autumn 2020, followed by a jump in transmissibility of the B.1.1.7/Alpha lineage. The Alpha variant grew when other lineages declined during the second national lockdown and regionally tiered restrictions between November and December 2020. A third more stringent national lockdown suppressed the Alpha variant and eliminated nearly all other lineages in early 2021. Yet a series of variants (most of which contained the spike E484K mutation) defied these trends and persisted at moderately increasing proportions. However, by accounting for sustained introductions, we found that the transmissibility of these variants is unlikely to have exceeded the transmissibility of the Alpha variant. Finally, B.1.617.2/Delta was repeatedly introduced in England and grew rapidly in early summer 2021, constituting approximately 98% of sampled SARS-CoV-2 genomes on 26 June 2021.
format Online
Article
Text
id pubmed-8674138
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86741382021-12-29 Genomic reconstruction of the SARS-CoV-2 epidemic in England Vöhringer, Harald S. Sanderson, Theo Sinnott, Matthew De Maio, Nicola Nguyen, Thuy Goater, Richard Schwach, Frank Harrison, Ian Hellewell, Joel Ariani, Cristina V. Gonçalves, Sonia Jackson, David K. Johnston, Ian Jung, Alexander W. Saint, Callum Sillitoe, John Suciu, Maria Goldman, Nick Panovska-Griffiths, Jasmina Birney, Ewan Volz, Erik Funk, Sebastian Kwiatkowski, Dominic Chand, Meera Martincorena, Inigo Barrett, Jeffrey C. Gerstung, Moritz Nature Article The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus leads to new variants that warrant timely epidemiological characterization. Here we use the dense genomic surveillance data generated by the COVID-19 Genomics UK Consortium to reconstruct the dynamics of 71 different lineages in each of 315 English local authorities between September 2020 and June 2021. This analysis reveals a series of subepidemics that peaked in early autumn 2020, followed by a jump in transmissibility of the B.1.1.7/Alpha lineage. The Alpha variant grew when other lineages declined during the second national lockdown and regionally tiered restrictions between November and December 2020. A third more stringent national lockdown suppressed the Alpha variant and eliminated nearly all other lineages in early 2021. Yet a series of variants (most of which contained the spike E484K mutation) defied these trends and persisted at moderately increasing proportions. However, by accounting for sustained introductions, we found that the transmissibility of these variants is unlikely to have exceeded the transmissibility of the Alpha variant. Finally, B.1.617.2/Delta was repeatedly introduced in England and grew rapidly in early summer 2021, constituting approximately 98% of sampled SARS-CoV-2 genomes on 26 June 2021. Nature Publishing Group UK 2021-10-14 2021 /pmc/articles/PMC8674138/ /pubmed/34649268 http://dx.doi.org/10.1038/s41586-021-04069-y Text en © The Author(s) 2021, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Vöhringer, Harald S.
Sanderson, Theo
Sinnott, Matthew
De Maio, Nicola
Nguyen, Thuy
Goater, Richard
Schwach, Frank
Harrison, Ian
Hellewell, Joel
Ariani, Cristina V.
Gonçalves, Sonia
Jackson, David K.
Johnston, Ian
Jung, Alexander W.
Saint, Callum
Sillitoe, John
Suciu, Maria
Goldman, Nick
Panovska-Griffiths, Jasmina
Birney, Ewan
Volz, Erik
Funk, Sebastian
Kwiatkowski, Dominic
Chand, Meera
Martincorena, Inigo
Barrett, Jeffrey C.
Gerstung, Moritz
Genomic reconstruction of the SARS-CoV-2 epidemic in England
title Genomic reconstruction of the SARS-CoV-2 epidemic in England
title_full Genomic reconstruction of the SARS-CoV-2 epidemic in England
title_fullStr Genomic reconstruction of the SARS-CoV-2 epidemic in England
title_full_unstemmed Genomic reconstruction of the SARS-CoV-2 epidemic in England
title_short Genomic reconstruction of the SARS-CoV-2 epidemic in England
title_sort genomic reconstruction of the sars-cov-2 epidemic in england
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674138/
https://www.ncbi.nlm.nih.gov/pubmed/34649268
http://dx.doi.org/10.1038/s41586-021-04069-y
work_keys_str_mv AT vohringerharalds genomicreconstructionofthesarscov2epidemicinengland
AT sandersontheo genomicreconstructionofthesarscov2epidemicinengland
AT sinnottmatthew genomicreconstructionofthesarscov2epidemicinengland
AT demaionicola genomicreconstructionofthesarscov2epidemicinengland
AT nguyenthuy genomicreconstructionofthesarscov2epidemicinengland
AT goaterrichard genomicreconstructionofthesarscov2epidemicinengland
AT schwachfrank genomicreconstructionofthesarscov2epidemicinengland
AT harrisonian genomicreconstructionofthesarscov2epidemicinengland
AT hellewelljoel genomicreconstructionofthesarscov2epidemicinengland
AT arianicristinav genomicreconstructionofthesarscov2epidemicinengland
AT goncalvessonia genomicreconstructionofthesarscov2epidemicinengland
AT jacksondavidk genomicreconstructionofthesarscov2epidemicinengland
AT johnstonian genomicreconstructionofthesarscov2epidemicinengland
AT jungalexanderw genomicreconstructionofthesarscov2epidemicinengland
AT saintcallum genomicreconstructionofthesarscov2epidemicinengland
AT sillitoejohn genomicreconstructionofthesarscov2epidemicinengland
AT suciumaria genomicreconstructionofthesarscov2epidemicinengland
AT goldmannick genomicreconstructionofthesarscov2epidemicinengland
AT panovskagriffithsjasmina genomicreconstructionofthesarscov2epidemicinengland
AT genomicreconstructionofthesarscov2epidemicinengland
AT genomicreconstructionofthesarscov2epidemicinengland
AT birneyewan genomicreconstructionofthesarscov2epidemicinengland
AT volzerik genomicreconstructionofthesarscov2epidemicinengland
AT funksebastian genomicreconstructionofthesarscov2epidemicinengland
AT kwiatkowskidominic genomicreconstructionofthesarscov2epidemicinengland
AT chandmeera genomicreconstructionofthesarscov2epidemicinengland
AT martincorenainigo genomicreconstructionofthesarscov2epidemicinengland
AT barrettjeffreyc genomicreconstructionofthesarscov2epidemicinengland
AT gerstungmoritz genomicreconstructionofthesarscov2epidemicinengland